Impairments in worker productivity and health-related quality of life among employees with irritable bowel syndrome: does bowel habit predominance make a difference?

Dean, Bonnie B; Aguilar, Daniel; Barghout, Victoria; Kahler, Kristijan; Groves, David; Ofman, Joshua J
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS233
Academic Journal
An abstract of the article "Impairments in worker productivity and health-related quality of life among employees with irritable bowel syndrome: does bowel habit predominance make a difference?" by Bonnie B. Dean and colleagues is presented.


Related Articles

  • The IBS-36: a new quality of life measure for irritable bowel syndrome. Groll, Dianne; Vanner, Stephen J.; Depew, William T.; DaCosta, Laurington R.; Simon, Jerome B.; Groll, Aubrey; Roblin, Nancy; Paterson, William G. // American Journal of Gastroenterology;Apr2002, Vol. 97 Issue 4, p962 

    OBJECTIVE:We aimed to develop and validate a quality of life instrument for patients with irritable bowel syndrome (IBS).METHODS:Using focus groups, existing questionnaires, and literature reviews, five IBS patients and nine gastroenterologists compiled and pilot tested for content validity a...

  • Meaningful QOL gains with alosetron in women with IBS-D.  // PharmacoEconomics & Outcomes News;8/18/2012, Issue 660, p9 

    The article discusses research on the quality of life of women with severe diarrhoea-predominant irritable bowel syndrome (IBS-D) who are taking alosetron, referencing a study by F. Cremonini and colleagues published in the July 10, 2012 issue of "Alimentary Pharmacology and Therapeutics."

  • Quality of Life in Irritable Bowel Syndrome. Lea, R.; Whorwell, P.J. // PharmacoEconomics;Jun2001, Vol. 19 Issue 6, p643 

    Quality-of-life (QOL) assessment is becoming increasingly important in the evaluation of the impact of disease and the effect of therapy. This is particularly so for irritable bowel syndrome (IBS) where there is often a tendency for a chronic clinical course, but with no associated mortality....

  • Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Akehurst, R.L.; Brazier, J.E.; Mathers, N.; O'Keefe, C.; Kaltenthaler, E.; Morgan, A.; Platts, M.; Walters, S.J.; Akehurst, Ron L; Brazier, John E; Mathers, Nigel; O'Keefe, Caroline; Kaltenthaler, Eva; Morgan, Anne; Platts, Maria; Walters, Stephen J // PharmacoEconomics;2002, Vol. 20 Issue 7, p455 

    Objectives: To identify the impact of irritable bowel syndrome (IBS) on health-related quality of life (HR-QOL), time off work and the utilisation and cost of health services. Design: A case-control study was undertaken matching patients with IBS and controls....

  • Assessing quality of life for patients with IBS.  // Patient Care;Nov2004, Vol. 38 Issue 11, p9 

    Reports on a study by researchers at the Veterans' Administration of Greater Los Angeles healthcare System in California that assessed the health-related quality of life (HRQOL) of patients with irritable bowel syndrome. Number of participants in the study; Factors that independently predicted...

  • IBS severity and health-related quality of life improve with age in women but not in men. Palsson, Olafur S; Whitehead, William E; Barghout, Victoria; Levy, Rona; Feld, Andrew; Von Korff, Michael; Garner, Michelle; Drossman, Douglas A; Turner, Marsha J // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS272 

    An abstract of the article "IBS severity and health-related quality of life improve with age in women but not in men," by Olafur S. Palsson and colleagues is presented.

  • HYPNOTHERAPY FOR IBS. CRUICKSHANKS, PAMELA // Healthcare Counselling & Psychotherapy Journal;Jul2013, Vol. 13 Issue 3, p33 

    The article presents an overview of a hypnotherapy treatment program for patients with irritable bowel syndrome (IBS) which is offered to IBS patients who have not responded to traditional treatment by the hypnotherapy unit at Wythenshawe Hospital in Manchester, England. Guidelines which have...

  • Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium. Kang Nyeong Lee; Oh Young Lee; Myung-Gyu Choi; Chong Il Sohn; Kyu Chan Huh; Kyung Sik Park; Joong Goo Kwon; Nayoung Kim; Poong-Lyul Rhee; Seung-Jae Myung; Joon Seong Lee; Kwang Jae Lee; Hyojin Park; Yong Chan Lee; Suck Chei Choi; Hye-Kyung Jung; Sam Ryong Jee; Chang Hwan Choi; Gwang Ha Kim; Moo In Park // Journal of Neurogastroenterology & Motility;Jan2014, Vol. 20 Issue 1, p113 

    Background/Aims Antispasmodics such as octylonium are widely used to manage irritable bowel syndrome (IBS) symptoms. However, the efficacy and safety of another antispasmodic, tiropramide, remain uncertain. We aimed to evaluate the efficacy and safety of tiropramide compared with octylonium in...

  • Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS-Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective... Hou, Xiaohua; Chen, Shengliang; Zhang, Yali; Sha, Weihong; Yu, Xiaofeng; Elsawah, Hesham; Afifi, Afifi; El-Khayat, Hisham; Nouh, Alaa; Hassan, Mohamed; Fatah, Ayman; Rucker Joerg, Isabel; Sánchez Núñez, Juan; Osthoff Rueda, Rodolfo; Jurkowska, Grazyna; Walczak, Michal; Malecka-Panas, Ewa; Linke, Krzysztof; Hartleb, Marek; Janssen-van Solingen, Gwendolyn // Clinical Drug Investigation;Nov2014, Vol. 34 Issue 11, p783 

    Background and Objective: Irritable Bowel Syndrome (IBS) has a substantial impact on health-related quality of life (HR-QoL) but high-quality data pre- and post-treatment using the IBS-Quality of Life (IBS-QOL) measure are limited. The objective of this study was to evaluate the changes from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics